There's been plenty of insider buying among S&P/ASX 200 Index (ASX: XJO) shares this week, with one director snapping up a whopping $198,000 stake in their company.
Let's take a closer look at all the action going down among market favourites.
Image source: Getty Images
6 ASX 200 directors buying their own companies' shares
The spotlight might be on ASX 200 lithium share Allkem Ltd (ASX: AKE) this week after the company's chair Peter Coleman snapped up a sizeable chunk of its securities.
He bought 17,054 Allkem shares between Friday and Tuesday, paying an average of around $11.61 apiece to more than double his holding. That equals a total spend of nearly $198,000.
The buying spree saw the boss bolstering his stake for a bargain price if Goldman Sachs is to be believed. The top broker tipped the Allkem share price to soar to $15.40 earlier this week, as my Fool colleague James reports.
Also the subject of insider buying this week is Charter Hall Retail REIT (ASX: CQR). The real estate investment trust's (REIT's) chair Roger Davis bought 38,669 units for around $3.98 apiece on Monday.
Over at banking giant Commonwealth Bank of Australia (ASX: CBA), director Anne Templeman-Jones was buying. She snapped up 300 shares for an average price of $101.10 apiece.
Meanwhile, Bapcor Ltd (ASX: BAP) saw not one, but two board members buying up its shares this week.
Chair Margaret Anne Haseltine bought 7,515 shares for $6.65 apiece while director Brad Soller bought 7,500 for the slightly higher price of $6.66 apiece.
Gold miner Regis Resources Ltd (ASX: RRL) has also seen insider buying this week. Director Paul Arndt bought into the company on Tuesday, acquiring 9,273 shares for a total of around $15,857, or approximately $1.71 apiece.
And finally, Healius Ltd (ASX: HLS) chair Jenny McDonald bolstered her stake in the pathology giant, buying 37,500 shares for $2.751 apiece – a total spend of around $103,000.
